Details for Patent: 10,105,444
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 10,105,444 protect, and when does it expire?
Patent 10,105,444 protects JUBLIA and is included in one NDA.
Summary for Patent: 10,105,444
Title: | Compositions and methods for treating diseases of the nail |
Abstract: | Methods and compositions for treating disorders of the nail and nail bed. Such compositions contain a vehicle in which all components of the composition are dissolved, suspended, dispersed, or emulsified, a non-volatile solvent, a wetting agent, and a pharmaceutically active ingredient that is soluble in the non-volatile solvent and/or a mixture of the vehicle and the non-volatile solvent, which composition has a surface tension of 40 dynes/cm or less and has continuing spreadability, and which composition is effective in treating a disorder of the nail or nail bed. |
Inventor(s): | Winckle; Gareth (Petaluma, CA), Fieldson; Gregory T. (Morgantown, WV) |
Assignee: | Dow Pharmaceutical Sciences, Inc. (Petaluma, CA) |
Application Number: | 15/826,109 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,105,444 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; Delivery; |
Drugs Protected by US Patent 10,105,444
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | JUBLIA | efinaconazole | SOLUTION;TOPICAL | 203567-001 | Jun 6, 2014 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |